4D Molecular Therapeutics Inc Tangible Net Worth Ratio
4D Molecular Therapeutics Inc tangible net worth ratio. 4D Molecular Therapeutics Inc (FDMT) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($505.66 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of 4D Molecular Therapeutics Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of 4D Molecular Therapeutics Inc (2020–2025)
Tangible net worth ratio of 4D Molecular Therapeutics Inc from 2020 to 2025. This chart shows how 4D Molecular Therapeutics Inc's Tangible Net Worth Ratio has changed across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $505.66 Million with intangible assets of $0.00 USD. Check asset allocation strategy of 4D Molecular Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
4D Molecular Therapeutics Inc Tangible Net Worth Ratio by Year (2020–2025)
4D Molecular Therapeutics Inc tangible net worth ratio by year from 2020 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for 4D Molecular Therapeutics Inc from 2020 to 2025, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 4D Molecular Therapeutics Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $505.66 Million | $0.00 | $566.71 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $510.61 Million | $0.00 | $560.38 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $307.83 Million | $0.00 | $339.89 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $231.34 Million | $0.00 | $261.85 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $319.11 Million | $0.00 | $353.49 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $256.39 Million | $0.00 | $288.33 Million | — |